In conditions associated with high serum iodothyronine sulfate concentrations, e.g. during fetal development, desulfation of these conjugates may be important in the regulation of thyroid hormone homeostasis. However, little is known about which sulfatases are involved in this process. Therefore, we investigated the hydrolysis of iodothyronine sulfates by homogenates of V79 cells expressing the human arylsulfatases A (ARSA), B (ARSB), or C (ARSC; steroid sulfatase), as well as tissue fractions of human and rat liver and placenta. We found that only the microsomal fraction from liver and placenta hydrolyzed iodothyronine sulfates. Among the recombinant enzymes only the endoplasmic reticulum-associated ARSC showed activity toward iodothyronine sulfates; the soluble lysosomal ARSA and ARSB were inactive. Recombinant ARSC as well as human placenta microsomes hydrolyzed iodothyronine sulfates with a substrate preference for 3,3-diiodothyronine sulfate (3,3-T 2 S) ϳ T 3 sulfate (T 3 S) Ͼ Ͼ rT 3 S ϳ T 4 S, whereas human and rat liver microsomes showed a preference for 3,3-T 2 S > T 3 S Ͼ Ͼ rT 3 S ϳ T 4 S. ARSC and the tissue microsomal sulfatases were all characterized by high apparent K m values (>50 M) for 3,3-T 2 S and T 3 S. Iodothyronine sulfatase activity determined using 3,3-T 2 S as a substrate was much higher in human liver microsomes than in human placenta microsomes, although ARSC is expressed at higher levels in human placenta than in human liver. The ratio of estrone sulfate to T 2 S hydrolysis in human liver microsomes (0.2) differed largely from that in ARSC homogenate (80) and human placenta microsomes (150). These results suggest that ARSC accounts for the relatively low iodothyronine sulfatase activity of human placenta, and that additional arylsulfatase(s) contributes to the high iodothyronine sulfatase activity in human liver. Further research is needed to identify these iodothyronine sulfatases, and to study the physiological importance of the reversible sulfation of iodothyronines in thyroid hormone metabolism. (Endocrinology 143: 814 -819,  2002) 
In conditions associated with high serum iodothyronine sulfate concentrations, e.g. during fetal development, desulfation of these conjugates may be important in the regulation of thyroid hormone homeostasis. However, little is known about which sulfatases are involved in this process. Therefore, we investigated the hydrolysis of iodothyronine sulfates by homogenates of V79 cells expressing the human arylsulfatases A (ARSA), B (ARSB), or C (ARSC; steroid sulfatase), as well as tissue fractions of human and rat liver and placenta. We found that only the microsomal fraction from liver and placenta hydrolyzed iodothyronine sulfates. Among the recombinant enzymes only the endoplasmic reticulum-associated ARSC showed activity toward iodothyronine sulfates; the soluble lysosomal ARSA and ARSB were inactive. Recombinant ARSC as well as human placenta microsomes hydrolyzed iodothyronine sulfates with a substrate preference for 3,3-diiodothyronine sulfate (3,3-T 2 S) ϳ T 3 sulfate (T 3 S) Ͼ Ͼ rT 3 S ϳ T 4 S, whereas human and rat liver microsomes showed a preference for 3,3-T 2 S > T 3 S Ͼ Ͼ rT 3 S ϳ T 4 S. ARSC and the tissue microsomal sulfatases were all characterized by high apparent K m values (>50 M) for 3,3-T 2 S and T 3 S. Iodothyronine sulfatase activity determined using 3,3-T 2 S as a substrate was much higher in human liver microsomes than in human placenta microsomes, although ARSC is expressed at higher levels in human placenta than in human liver. The ratio of estrone sulfate to T 2 S hydrolysis in human liver microsomes (0.2) differed largely from that in ARSC homogenate (80) and human placenta microsomes (150). These results suggest that ARSC accounts for the relatively low iodothyronine sulfatase activity of human placenta, and that additional arylsulfatase(s) contributes to the high iodothyronine sulfatase activity in human liver. Further research is needed to identify these iodothyronine sulfatases, and to study the physiological importance of the reversible sulfation of iodothyronines in thyroid hormone metabolism. (Endocrinology 143: 814 -819,  2002) S ULFATION IS AN important metabolic pathway that facilitates the inactivation and elimination of lipophilic exogenous and endogenous compounds, including thyroid hormones, by increasing their water solubility (1) (2) (3) . A more important purpose for the sulfation of thyroid hormones is to facilitate their degradation by the type I iodothyronine deiodinase (D1) (4 -7). D1 catalyzes the outer ring deiodination (activation) of T 4 to T 3 as well as the inner ring deiodination (IRD; inactivation) of T 4 to rT 3 and of T 3 to 3,3Ј-diiodothyronine (3,3Ј-T 2 ) (5). As IRD of sulfated T 4 and T 3 by D1 is accelerated 40-to 200-fold, whereas outer ring deiodination of T 4 sulfate (T 4 S) is completely blocked (4 -7), sulfation has an important role in the irreversible inactivation of thyroid hormone by D1. However, when D1 activity is low or clearance of iodothyronine sulfates is otherwise impaired, inactivation of thyroid hormone by sulfation may be reversible due to the expression of arylsulfatases in different tissues (8 -10) or the presence of bacterial sulfatases in the intestine (11) . Strongly elevated iodothyronine sulfate concentrations have been found in fetal and neonatal serum and in amniotic fluid in humans and sheep (12) (13) (14) (15) (16) . Thyroid hormone is essential for the normal fetal development of several organs, in particular the brain (17) (18) (19) (20) . Therefore, it has been speculated that these iodothyronine sulfates, especially T 3 S, function as a pool of inactive thyroid hormone from which the active hormone is released in a tissue-specific and development stage-dependent manner (7, 9, 12, 14, 21) . Iodothyronine sulfatase activities are present in human fetal liver and lung, and become undetectable in lung after birth (22) . In rats, which are born immature compared with humans, hepatic T 3 S sulfatase activity progressively increases after birth until 2 months of age (23) .
Hydrolysis of sulfate conjugates is an enzymatic process, and multiple arylsulfatases have now been identified (24) . Arylsulfatase A (ARSA) and arylsulfatase B (ARSB) are soluble enzymes, localized in lysosomes. To date, sulfated glycolipids have been identified as endogenous substrates for ARSA, whereas ARSB has a known substrate specificity for dermatan sulfate and chondroitin sulfate (25) . These sulfatases are widely distributed, although in the pig ARSA activity is 20 -60 times higher in the thyroid than in other tissues (26) . Arylsulfatase C (ARSC), also termed steroid sulfatase, is located in the endoplasmic reticulum, and hydrolyzes steroid sulfates such as dehydroepiandrosterone sulfate (DHEAS), estrone sulfate (E1S), and cholesterol sulfate (25) . We have recently demonstrated that iodothyronines are good substrates for estrogen sulfotransferase (27) . Therefore, it seems logical to assume that iodothyronine sulfates are also good substrates for the steroid sulfatase ARSC. This isoenzyme is expressed in many tissues, including placenta and liver (28 -31) . In the placenta, ARSC plays a major role in estrogen biosynthesis from DHEAS, which is mainly produced in the fetal adrenal gland and is converted to 16␣-hydroxy-DHEAS by the fetal liver (32) . Recently, a group of novel ARS genes was identified, clustered on Xp22.3 (33) (34) (35) , near the ARSC gene. ARSD␣ and -␤ and ARSF have been localized in the endoplasmic reticulum, whereas ARSE is located in the Golgi apparatus (35, 36) . The endogenous substrates for these arylsulfatases remain to be identified, although neither ARSE nor ARSF hydrolyzes steroid sulfates (33) (34) (35) (36) . ARSD does not appear to act as a conventional arylsulfatase, as no such activity has yet been determined for the recombinant protein (34, 35) . They also differ from ARSC in that they are thermolabile.
Earlier studies demonstrated T 3 S sulfatase activities in human and rat liver microsomes and in rat hepatocytes (9, 21). However, not much is known about which sulfatases are responsible for the hydrolysis of sulfated iodothyronines. Therefore, we studied the arylsulfatases ARSA, ARSB, and ARSC and the sulfatase activities in human and rat liver and placenta using iodothyronine sulfates as substrates to determine whether these arylsulfatases are involved in hydrolysis of thyroid hormone sulfates in tissues.
Materials and Methods Materials
Rat livers were isolated from adult male Wistar rats, and normal human liver was obtained at surgery for liver tumors. Normal human placental tissue was obtained at spontaneous, full-term delivery, and rat placenta was obtained after cesarean section at 20 d gestational age. Approval was obtained from institutional committees. Cytosolic and microsomal fractions of the different tissues were prepared as previously described (4, 37) . Human ARSA, ARSB, and ARSC cDNA clones were provided by Prof. K. von Figura (University of Gö ttingen, Gö ttingen, Germany) and expressed in V79 Chinese hamster lung fibroblast cells as previously described (25) . 125 I-Labeled and unlabeled T 4 S, rT 3 S, T 3 S, and 3,3Ј-T 2 S were prepared by reaction of labeled and unlabeled T 4 , rT 3 , T 3 , and 3,3Ј-T 2 with chlorosulfonic acid in dimethylformamide. They were purified by LH-20 chromatography (38) .
Sulfatase assay
Iodothyronine sulfatase activity was assayed by incubation of 0.1 m unlabeled and 100,000 cpm 125 I-labeled T 4 S, rT 3 S, T 3 S, or 3,3Ј-T 2 S and 0.1 or 1 mm PTU (to block D1 activity) for 60 min at 37 C with the indicated amounts of tissue cytosol or microsomes or V79 cell homogenate in 0.2 ml buffer. Optimal assay conditions for the different sulfatases were determined by testing different buffers (0.1 m sodium acetate, sodium citrate, Tris-HCl, sodium phosphate, or BTP-HCl), pH values, and temperatures. The reactions were started by the addition of enzyme in ice-cold buffer and were stopped by the addition of 0.8 ml 0.1 m HCl. The mixtures were analyzed for T 4 , rT 3 , T 3 , or 3,3Ј-T 2 formation by chromatography on Sephadex LH-20 minicolumns as previously described (39) . Desulfation in complete reaction mixtures was corrected for background radioactivity detected in the corresponding Sephadex LH-20 fractions of control incubations without enzyme.
Estrogen sulfatase activity was analyzed by incubation of 0.1 m [ 3 H]E1S for 0 (blank) or 30 min at 37 C with the indicated amounts of tissue microsomes or V79 cell homogenate in 0.1 ml 0.1 m Tris-HCl (pH 7.2). The reactions were stopped by the addition of 0.4 ml 0.1 m Tris-HCl (pH 8.8), and the mixtures were extracted with 2.5 ml chloroform. Sulfate hydrolysis was quantified by counting 0.25 ml of the aqueous phase. The amount of E1S still present in complete reaction mixtures after 30 min at 37 C was compared with the amount of E1S present in the corresponding nonincubated reaction mixtures. Figure 1 shows the pH profiles of the desulfation of 0.1 m 3,3Ј-T 2 S by rat liver and human liver microsomes and recombinant human ARSC obtained using acetate and BTPHCl buffers. Rat liver microsomal sulfatase showed an optimum at pH 6.0 -6.5 (Fig. 1A) , human liver microsomal sulfatase at pH 6.0 -7.5 (Fig. 1B) , and ARSC at approximately pH 7.0 (Fig. 1C) . At neutral pH, the different enzymes showed similar sulfatase activities in BTP-HCl and Tris-HCl buffers, but much lower activities in phosphate buffer ( Fig.  2A) . At acidic pH values, incubations of the different enzymes, in particular human liver, in citrate buffer strongly inhibited their 3,3Ј-T 2 S sulfatase activities compared with incubations in acetate buffer (Fig. 2B) . Similar results were obtained in buffers with or without 2 mm EDTA (not shown). Figure 3 demonstrates the effects of temperature on the desulfation of 0.1 m 3,3Ј-T 2 S by human and rat liver microsomes. The optimal temperature for human liver microsomes is 50 C, and that for rat liver microsomes is 70 C or higher. Figure 4 presents the desulfation of 0.1 m T 4 S, T 3 S, rT 3 S, and 3,3Ј-T 2 S by recombinant human ARSC and human and rat placenta and liver microsomes at pH 7.2. ARSC showed similar activities toward 3,3Ј-T 2 S and T 3 S, whereas both rT 3 S and T 4 S were poor substrates for this enzyme. The substrate specificity of human placenta microsomes was similar to that of ARSC. Very high desulfation rates were observed in human liver microsomes, with a strong substrate preference for 3,3Ј-T 2 S, which was hydrolyzed about 4 times faster than T 3 S (i.e. desulfation rates of ϳ7.2 and 1.8 pmol/min⅐mg) and more than 10 times faster than the relatively poor substrates rT 3 S and T 4 S. Rat liver microsomes also showed a substrate preference for 3,3Ј-T 2 S, which was desulfated twice as fast as T 3 S; in rat placenta microsomes low desulfation rates (i.e. Ͻ0.1 pmol/min⅐mg) were observed with all iodothyronine sulfates. We also tested steroid sulfatase activities of ARSC and of human placenta and liver microsomes. Table 1 compares E1S and T 2 S sulfatase activities of ARSC and the different human tissue microsomes. The low ratio of E1S to T 2 S hydrolysis in liver microsomes differs largely from the high preference for E1S vs. T 2 S hydrolysis by ARSC and human placenta microsomes. Tested at the optimum pH 5.5, soluble ARSA and ARSB as well as rat and human liver cytosols showed very low activity toward all iodothyronine sulfates (results not shown). Figure 5 shows the desulfation of 3,3Ј-T 2 S by ARSC, human liver, and human placenta microsomes as a function of the substrate concentration. As no saturation was reached even at the highest concentration of 50 m, K m and maximum velocity values could not be calculated. Similar results were obtained when T 3 S was used as substrate. Apparently all of these sulfatases have low affinity for iodothyronine sulfates, with K m values greater than 50 m.
Results

Discussion
Normally, serum T 4 S and T 3 S levels are low (12, 40, 41) . This is explained by the very rapid deiodination of these conjugates, as sulfation strongly induces the D1-catalyzed IRD of both T 4 and T 3 (7). However, under certain (patho)-physiological conditions, e.g. during fetal development and nonthyroidal illness, possibly due to diminished D1 activity, plasma concentrations of iodothyronine sulfates are increased (12, 13, 16, 41) . T 3 S is considered to be biologically inert, as it has lost its affinity for the T 3 receptors (42). It could, however, serve as a reservoir from which active thyroid hormone is regenerated by tissue sulfatases or bacterial sulfatases in the intestine (8 -11) .
Recently, much research has been performed to develop inhibitors of steroid sulfatase (ARSC) because of their potential for the treatment of estrogen-dependent breast cancers (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) (54) . These studies have revealed some important structure-activity relations for compounds binding to the active site of ARSC. Furthermore, the crystal structures of arylsulfatases A and B have recently been elucidated (55, 56) . Although the overall amino acid sequence homology is only about 20 -30% between different arylsulfatases, the protein structures of all sulfatases share some important features. The active site of eukaryotic sulfatases contains a metal ion, probably Mg 2ϩ (56, 57) , and a formylglycine, generated by posttranslational modification of a cysteine residue (58 -61) . Residues interacting with Mg 2ϩ and formylglycine are conserved among the members of the sulfatase family. UhlhornDierks et al. (57) proposed a catalytic mechanism for the hydrolysis of sulfates by sulfatases based on their structure and mutational analyses. An intermediate enzyme-sulfate complex is formed by the covalent binding of sulfate to the hydrated formylglycine (i.e. dihydroxyalanine). When the active site formylglycine is replaced by a serine (i.e. hydroxy- alanine), the intermediate enzyme-sulfate complex is trapped (62) , which indicates that the second hydroxyl group of hydrated formylglycine is needed for sulfate release (57, 62) .
Crystallographic analyses (55, 56, 63 ) also revealed structural homology between alkaline phosphatases and arylsulfatases. A functional relationship between the enzymes was shown by O'Brien et al. (64) , who demonstrated that alkaline phosphatase exhibits a low level of sulfatase activity. They also showed inhibition of the phosphatase as well as the sulfatase activities of alkaline phosphatase by inorganic phosphate (64). Anderson et al. reported on steroidal and nonsteroidal phosphates that inhibited steroid sulfatase activity (43) . We demonstrated inhibition of the iodothyronine sulfatase activities by inorganic phosphate and citrate. Perhaps these anions block the active site of iodothyronine sulfatases. An alternative explanation is that citrate and phosphate inhibit iodothyronine sulfatase activity by complexing the enzyme-bound Mg 2ϩ . However, we did not observe inhibition of iodothyronine sulfatase activity in the presence of EDTA. Our results strongly suggest that iodothyronine sulfatase activities determined in phosphate buffers, as reported by others (9, 23) , represent a marked underestimation of true enzyme levels.
Whereas significant sulfatase activity toward 3,3Ј-T 2 S and T 3 S was found in human placenta, in rat placenta activity toward these iodothyronine sulfates was much lower. This difference in activity may be due to the species difference. It should be noted, however, that whereas the rat placental tissue used in this study consisted of both the fetal as well as the maternal side of the placenta, the human placental tissue mainly consisted of the fetal side of the placenta, as most of the maternal side (decidua) is not expelled at spontaneous delivery. Furthermore, the rat placenta was isolated at embryonic d 20, i.e. 1 d before birth, whereas human placenta was obtained at full-term delivery. Therefore, besides the species difference, these differences in tissue composition and developmental stage may also contribute to the different sulfatase activities found in human and rat placenta.
We showed a pH optimum for rat liver microsomes at pH 6.0 -6.5, for human liver microsomes at pH 6.0 -7.5, and for arylsulfatase C at pH 7.0. The broader peak for the human and rat liver microsomes might indicate that different sulfatases, with different pH optima, are involved in the desulfation of 3,3Ј-T 2 . Kung et al. (9) observed T 3 S sulfatase activities in human and rat liver microsomes. E1S and DHEAS, both substrates for ARSC, inhibited T 3 S hydrolysis with IC 50 values of approximately 10 m. The fact that high levels of E1S only partially inhibited T 3 S desulfation, whereas high DHEAS concentrations produced complete inhibition, supports the involvement of multiple sulfatases, possibly including ARSC (9) . However, these analyses were performed in phosphate buffer (9) , which may strongly affect the contributions of different sulfatases.
The optimal temperature of iodothyronine sulfatase activities is 50 C in human liver microsomes and at least 70 C in rat liver microsomes. The high thermostability of these sulfatases is in agreement with the temperature optimum of 60 C for ARSC (65) . ARSC and the sulfatase activities in human liver and placenta microsomes have high K m values for iodothyronine sulfates. The different substrate specificities of the iodothyronine sulfatase activity in human liver vs. ARSC and placenta as well as the finding that the ratio of E1S to T 2 S hydrolysis in human liver differs greatly from that in ARSC and placenta suggest that in human liver additional sulfatases to ARSC contribute to the hydrolysis of iodothyronine sulfates, in particular T 2 S. However, ARSD, ARSE, and ARSF are not likely candidates, as 1) both ARSE and ARSF are thermolabile, whereas iodothyronine sulfatase activity appears thermostable (33, 34) ; and 2) ARSD does not possess arylsulfatase activity (34, 35) .
It is remarkable that although 3,3Ј-T 2 is the preferred substrate for sulfotransferases, 3,3Ј-T 2 S is the preferred substrate for (human liver) sulfatase. Thus, reversible sulfation/desulfation seems a more important metabolic pathway for 3,3Ј-T 2 than for T 4 , T 3 , and rT 3 . This may reflect restrictions in the active sites of the sulfotransferase and sulfatase to accommodate bulky substrates with more than two iodine substituents. However, a physiological role for 3,3Ј-T 2 is not excluded. Although its affinity for the nuclear thyroid hormone receptors is low (17), 3,3Ј-T 2 has been shown to stimulate mitochondrial respiration in different tissues (66) .
In conclusion, we have identified arylsulfatase C as a high K m iodothyronine sulfatase that is most likely the main enzyme responsible for the hydrolysis of iodothyronine sulfates in human placenta and to some extent in human liver. Further investigations are needed to determine the possible importance of other, still unidentified, microsomal sulfatases in hydrolysis of iodothyronine sulfates in the liver and perhaps other tissues. This information may contribute to the understanding of the role of sulfation-desulfation in the regulation of thyroid hormone bioactivity, in particular during fetal development. 
